Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered 23Na MRI, 1H diffusion-weighted MRI and PET imaging

Magnetic Resonance Imaging

Volumn 25, Issue 7, 2007, Pages 1015-1023

  Babsky, Andriy M ^a   Zhang, Hong ^a   Hekmatyar, Shahryar K ^a   Hutchins, Gary D ^a   Bansal, Navin ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

23Na MRI; RIF 1; Therapy response; Water ADC

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; SODIUM 23; WATER;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; FIBROSARCOMA; GLYCOLYSIS; MALE; METABOLISM; MONITORING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION INDUCED FIBROSARCOMA; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG MONITORING; FIBROSARCOMA; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C3H; RADIOPHARMACEUTICALS; SODIUM; TEMPERATURE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; WATER;

ANIMALIA; MUS;

EID: 34547743761     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2006.11.004     Document Type: Article

References (23)

1. Chenevert T.L., Stegman L.D., Taylor J.M., Robertson P.L., Greenberg H.S., Rehemtulla A., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 (2000) 2029-2036
2. Ross B.D., Zhao Y.J., Neal E.R., Stegman L.D., Ercolani M., Ben-Yoseph O., et al. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci U S A 95 (1998) 7012-7017
3. Sijens P., Baldwin N., and Ng T. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magn Reson Med 19 (1991) 373-385
4. Li S., Wehrle J., Glickson J., Kumar N., and Braunschweiger P. Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magn Reson Med 22 (1991) 47-56
5. Aboagye E., Bhujwalla Z., Shungu D., and Glickson J. Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Res 58 (1998) 1063-1067
6. 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors. Neoplasia 7 (2005) 658-666
7. Schepkin V.D., Ross B.D., Chenevert T.L., Rehemtulla A., Sharma S., Kumar M., et al. Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma. Magn Reson Med 53 (2005) 85-92
8. Schepkin V., Chenevert T., Kuszpit K., Lee K., Meyer C., Johnson T., et al. Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. Magn Reson Imaging 24 (2006) 273-278
9. Winter P.M., and Bansal N. Triple-quantum-filtered (23)Na NMR spectroscopy of subcutaneously implanted 9l gliosarcoma in the rat in the presence of TmDOTP(5-1). J Magn Reson 152 (2001) 70-78
10. Winter P.M., Poptani H., and Bansal N. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Cancer Res 61 (2001) 2002-2007
11. Frese T., Rouze N., Bouman C., Sauer K., and Hutchins G. Quantitative comparison of FBP, EM, and Bayesian reconstruction algorithms for the IndyPET scanner. IEEE Trans Med Imaging 22 (2003) 258-276
12. Twentyman P.R., Brown J.M., Gray J.W., Franko A.J., Scoles M.A., and Kallman R.F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64 (1980) 595-604
13. Vinitski S., Griffey R., Fuka M., Matwiyoff N., and Prost R. Effect of the sampling rate on magnetic resonance imaging. Magn Reson Med 5 (1987) 278-285
14. 23Na imaging of rabbit kidney with weighted signal averaging. J Magn Reson Imaging 5 (1995) 761-767
15. 23Na NMR spectroscopy and imaging. In: Bruch M.D. (Ed). NMR spectroscopy technique (1996), Marcel Dekker, New York 557-607
16. 23Na imaging of the rat in vivo. ISMRM 3 (1997) 2116
17. Carano R.A., Ross A.L., Ross J., Williams S.P., Koeppen H., Schwall R.H., et al. Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 51 (2004) 542-551
18. Helmer K.G., Meiler M.R., Sotak C.H., and Petruccelli J.D. Comparison of the return-to-the-origin probability and the apparent diffusion coefficient of water as indicators of necrosis in RIF-1 tumors. Magn Reson Med 49 (2003) 468-478
19. Lemaire L., Howe F.A., Rodrigues L.M., and Griffiths J.R. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 8 (1999) 20-26
20. Braunschweiger P.G. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res 48 (1988) 4206-4210
21. McSheehy P., Leach M., Judson I., and Griffiths J. Metabolites of 2′-fluoro-2′-deoxy-d-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil. Cancer Res 60 (2000) 2122-2127
22. Barthel H., Cleij M., Collingridge D., Hutchinson O., Osman S., He Q., et al. 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 63 (2003) 3791-3798
23. Bhujwalla Z.M., McCoy C.L., Glickson J.D., Gillies R.J., and Stubbs M. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer 78 (1998) 606-611